Statins for influenza and pneumonia

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 1, 2017, Pages

  Khandaker, Gulam ^a   Rashid, Harunor ^a   Chow, Maria Y K ^a   Booy, Robert ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; INFLUENZA; PNEUMONIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

EID: 85008426296     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD008916.pub2     Document Type: Article

References (26)

1. Australian Bureau of Statistics. Causes of death in Australia 2007: leading causes of death. http://www.abs.gov.au/ausstats/abs@.nsf/mf/3303.0.
2. Almog Y, Novack V, Eisinger M, Porath A, Novack L, Glutz H. The effect of statin therapy on infection-related mortality in patients with atherosclerotic disease. Critical Care Medicine 2007;35:372-8.
3. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors. Annals of Internal Medicine 2009;151:JC4-14.
4. Dublin S, Jackson ML, Nelson JC, Weiss NS, Larson EB, Jackson LA. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009;338:b2137.
5. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
6. Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clinical Infectious Diseases 2006;43:199-205.
7. Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done?. Lancet Infectious Diseases 2008;8:571-6.
8. Fedson DS. Meeting the challenge of influenza pandemic preparedness in developing countries. Emerging Infectious Diseases 2009;15:365-71.
9. Furberg CD. Natural statins and stroke risk. Circulation 1999;99:185-8.
10. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
11. Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ 2006;332:3.
12. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clinical Infectious Diseases 2004;39:1642-50.
13. Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G. Statin therapy is associated with few deaths in patients with bacteremia. Intensive Care Medicine 2006;32:75-9.
14. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s) editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (updated February 2009). Chichester, UK: Wiley-Blackwell, 2009.
15. Miniño AM, Heron MP, Murphy SL, Kochanek KD. Deaths: final data for 2004. National Vital Statistics Reports 2007;55:1-119.
16. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Archives of Internal Medicine 2000;160:3243-7.
17. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm (Accessed 11 June 2010).
18. Ostapchuk M, Roberts DM, Haddy R. Community-acquired pneumonia in infants and children. American Family Physician 2004;70:899-908.
19. Plouffe JF, Herbert MT, File TM Jr, Baird I, Parsons JN, Kahn JB, et al. Ofloxacin versus standard therapy in treatment of community acquired pneumonia requiring hospitalization. Antimicrobial Agents and Chemotherapy 1996;40:5.
20. The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2008.
21. Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, et al. Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Archives of Internal Medicine 2009;169:1658-67.
22. Vandermeer M, Thomas A, Kamimoto L, et al. Role of statins in preventing death among patients hospitalized with lab-confirmed influenza infections. Infectious Diseases Society of America 47th Annual Meeting, October 29 to November 1, 2009 http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=09faaa5b-1623-4bf1-8edf-7ba49da11c36&cKey=0f97f4e4-5520-4c91-86ff-db4c23129b21 (accessed 3 November 2009). 2009:Oral abstract 706.
23. Wei L, Ebrahim S, Bartlett C, Davey PD, Sullivan FM, MacDonald TM. Statin use in the secondary prevention of coronary heart disease in primary care: cohort study and comparison of inclusion and outcome with patients in randomised trials. BMJ 2005;330:821.
24. World Health Organization. Influenza (Seasonal) Fact sheet No 211; Revised March 2003. Available from http://www.who.int/mediacentre/factsheets/2003/fs211/en/ 2003.
25. World Health Organization. Pandemic (H1N1) 2009 - update 97. http://www.who.int/csr/don/2010_04_23a/en/index.html 2009.
26. World Health Organization. World Health Statistics. Geneva, WHO 2009.